26 Jan 2012 14:23
ο»Ώ
26 January 2012
Β
Microgen plc (the "Company")
Β
Notifiable Interests
Β
The Company received the following notice on 25 January 2012 in compliance with the Disclosure and Transparency Rules from Aberforth Partners LLP:
Β
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Microgen PLC | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | YES | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | ||||
Other (please specify): | ||||
3. Full name of person(s) subject to thenotification obligation: iii | Aberforth Partners LLP | |||
4. Full name of shareholder(s) Β (if different from 3.):iv | Shareholder: Shares: 1. Aberforth Smaller Companies Trust plc 6,155,526 2. Aberforth UK Small Companies Fund 1,561,351 3. Aberforth Geared Income Trust plc 1,607,900 Β All shares are registered in the name of Nortrust Nominees Ltd A/c Aberfrth | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 24/01/2012 | |||
6. Date on which issuer notified: | 25/01/2012 | |||
7. Threshold(s) that is/are crossed orreached: vi, vii | 12% | |||
Β
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
Ordinary | 9,998,277 | 9,998,277 | 9,324,777 | N/A | 9,324,777 | N/A | 11.46 | |||||||||
GB0005869531 | ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
N/A | N/A | N/A | N/A | N/A | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to Β | % of voting rights xix, xx Β | |||||||||||
N/A | N/A | N/A | N/A | Β N/A | Nominal | Delta | ||||||||||
N/A | N/A | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
9,324,777 | 11.46 | |||||||||||||||
Β
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
Held by Aberforth Partners LLP Β | ||
Proxy Voting: | ||
10. Name of the proxy holder: | N/A | |
11. Number of voting rights proxy holder will ceaseto hold: | N/A | |
12. Date on which proxy holder will cease to holdvoting rights: | N/A | |
13. Additional information: | In addition, Aberforth Partners LLP is interested in a further 2,885,400 shares although it does not have access to the voting rights of these shares. Aberforth Partners LLP is, therefore, interested in a total of 12,210,177 shares of Microgen plc. This interest arises as a result of the discretionary investment management powers that Aberforth Partners LLP can exercise over the funds of its clients. Aberforth Partners LLP is not the beneficial owner of these shares. | |
14. Contact name: | Pauline Robson, Aberforth Partners LLP | |
15. Contact telephone number: | 0131 220 0733 | |
Β
If you require further information please contact:
A. Siddiqi, Company Secretary Tel: 020 7496 8100
www.microgen.com
Β
Follow the stocks